Meltem ÇETİN
FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW
FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW
Pharmata
2022-Cilt: 2 Sayı: 4
114-124
Cardiovascular diseases,
fixed-Dose Combination,
orally Disintegrating Tablet,
Type 2 diabetes
377
72